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SUMMARY
Glucose hypometabolism in cortical structures after functional disconnection is frequently reported in pa-
tients with white matter diseases such as subcortical stroke. However, the molecular and cellular mecha-
nisms have been poorly elucidated. Here we show, in an animal model of internal capsular infarct, that
GABA-synthesizing reactive astrocytes in distant cortical areas cause glucose hypometabolism via tonic in-
hibition of neighboring neurons. We find that reversal of aberrant astrocytic GABA synthesis, by pharmaco-
logical inhibition and astrocyte-specific gene silencing of MAO-B, reverses the reduction in cortical glucose
metabolism. Moreover, induction of aberrant astrocytic GABA synthesis by cortical injection of putrescine or
adenovirus recapitulates cortical hypometabolism. Furthermore, MAO-B inhibition causes a remarkable re-
covery from post-stroke motor deficits when combined with a rehabilitation regimen. Collectively, our data
indicate that cortical glucose hypometabolism in subcortical stroke is caused by aberrant astrocytic
GABA and MAO-B inhibition and that attenuating cortical hypometabolism can be a therapeutic approach
in subcortical stroke.
INTRODUCTION
Subcortical stroke accounts for up to 30%of all ischemic strokes
in humans (Sacco et al., 2006) and is known for its poor prog-
nosis (Yamashita et al., 2016). In several white matter diseases,
including subcortical stroke and vascular dementia, the pres-
ence of regional glucose hypometabolism in the cortex has
been frequently reported (Chu et al., 2002; Tatsch et al., 2003).
This regional glucose hypometabolism is an important charac-
teristic of diaschisis, which is defined as a change in a distant
area following a focal brain injury (Finger et al., 2004). The
appearance of diaschisis has been closely associated with
both clinical symptoms (Carrera and Tononi, 2014) and recovery
from stroke (Seitz et al., 1999; Takasawa et al., 2002). However,
because of the lack of proper animal models, little is known
about the cellular and molecular etiology of cortical hypometab-
olism in subcortical stroke. Moreover, whether and how attenu-
ating cortical hypometabolism can promote the functional recov-
ery after subcortical stroke have been largely unexplored.
We have recently developed a rat model of capsular infarct us-
ing the focal photo-thrombosis technique and successfully re-
produced an appearance of diaschisis in cortical areas (Kim
et al., 2014, 2015). We reported that electrical stimulation of
the cortical diaschisis region caused a significant reversal of
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diaschisis and recovery from post-stroke motor deficits when
combined with rehabilitation, while rehabilitation alone did not
(Kim et al., 2016). However, how electrical stimulation caused
the reversal of diaschisis was not revealed in the previous study.
Given that cortical hypometabolism in diaschisis is tightly asso-
ciated with reduced neuronal and synaptic activities (Lundgaard
et al., 2015), here we postulate that the cortical hypometabolism
is caused by the inhibitory action of GABA.
Astrogliosis, a characteristic reaction of astrocytes to an injury
or disease with morphological alteration, has been reported to
be present in the diaschisis region, as well as in the infarct areas
of brains with stroke (Badan et al., 2003; Burda and Sofroniew,
2014; Garbuzova-Davis et al., 2013). In addition, we have previ-
ously reported that excessive GABA from reactive astrocytes
aberrantly suppresses neighboring neuronal activity (Heo et al.,
2020; Jo et al., 2014; Pandit et al., 2020; Shim et al., 2019;
Yoon et al., 2014). Aberrant GABA synthesis in reactive astro-
cytes has been observed in the hippocampus in Alzheimer’s dis-
ease mouse models and the temporal cortex in postmortem
brains from Alzheimer’s disease patients (Jo et al., 2014; Wu
et al., 2014), the hippocampus in a kainate-induced seizure
model (Pandit et al., 2020), the hypothalamus in an inflammatory
cytokine-induced anxiety-like behavior model (Shim et al., 2019),
and the substantia nigra pars compacta in various animalmodels
and patients with Parkinson’s disease (Heo et al., 2020). From
these previous studies, we hypothesized that aberrant GABA
synthesized and released from reactive astrocytes causes a
reduction in regional metabolism in the diaschisis region by
excessive GABA to inhibit the synaptic activity of neighboring
cortical neurons. Furthermore, we tested the possibility that as-
trocytic GABA-mediated glucose hypometabolism impedes
functional recovery by rehabilitation-mediated activation of mo-
tor circuits.
RESULTS
MAO-B as the Key Mediator for Glucose
Hypometabolism
To monitor the generation and maintenance of diaschisis in the
capsular infarct model with distinct damage of corticospinal mo-
tor fibers and astrogliosis in the internal capsule (Figures 1A and
1B), we performed longitudinal 2-deoxy-2-[18F]-fluoro-D-
glucose micro-positron emission tomography (FDG-microPET).
We found that the ipsilesional cortices in the capsular infarct
model displayed extensive glucose hypometabolism (i.e., dia-
schisis) at day 7 after stroke operation. This cortical glucose hy-
pometabolism was sustained for more than 2 weeks, as evi-
denced by significantly increased cortical diaschisis volume,
which did not appear in sham-operated animals (Figures 1C,
1D, and S1). We also found that infarction of the internal capsule
significantly decreased normalized metabolic activity (NMA),
which is each voxel’s standardized uptake value (SUV) of FDG
normalized to the averaged SUV throughout the whole brain, in
the primary motor cortex (M1; Figures 1E and S1). M1 is a highly
relevant brain region to post-stroke motor deficits (Li et al.,
2016). Next, we tested whether excessive GABA synthesis
from reactive astrocytes is the key mediator of diaschisis by us-
ing a recently developed selective and reversible inhibitor of
monoamine oxidase-B (MAO-B), KDS2010, which has been
confirmed to effectively block astrocytic GABA synthesis (Park
et al., 2019). Intriguingly, we found a dramatic decrease of
cortical diaschisis volume (Figure 1D) and a significant recovery
of glucose metabolism in M1 by KDS2010 administration (Fig-
ures 1E and S1). These results suggest astrocytic GABA as the
key mediator for cortical glucose hypometabolism.
Excessive GABA from Reactive Astrocytes in the
Diaschisis Region
MAO-B is known as the key enzyme for astrocytic GABA synthe-
sis through the putrescine degradation pathway (Yoon et al.,
2014). Given that glucose hypometabolism is tightly associated
with reduced synaptic activity (Lundgaard et al., 2015), the
reversal of diaschisis by MAO-B inhibitor treatment is attributed
to prevention of aberrant inhibition of synaptic activities by
excessive GABA. Therefore, we examined astrocytic GABA in
the diaschisis region by performing immunohistochemistry with
antibodies against GABA andMAO-B. We found that immunore-
activities of GABA and MAO-B were significantly increased in
reactive astrocytes in the diaschisis region in the capsular infarct
model compared with sham-operated animals (Figures 2A, 2B,
2E, and S2). Astrocytic reactivity was defined by an increased
ramification index assessed using Sholl analysis (Figures 2C
and 2D), increased GFAP-positive area (Figure S2C), and
increased mRNA levels of various markers for reactive astro-
cytes, such as GFAP, MAO-B, inducible nitric oxide synthase
(iNOS) (Endoh et al., 1994), LCN2 (Bi et al., 2013), and vimentin
(Mucke and Eddleston, 1993) (Figure S2G). On the other hand,
we found no significant alteration of neuronal GABA (Figures
S3A and S3B). Meanwhile, MAO-B inhibition by KDS2010 treat-
ment significantly restored from aberrant astrocytic GABA (Fig-
ures 2C–2E), elevated protein level and enzymatic activity of
MAO-B, and elevated mRNA levels of astrocytic reactivity
markers (Figure S2). Notably, we found a significant negative
correlation between astrocytic GABA level and NMA in the dia-
schisis region (Figure 2F), suggesting that astrocytic GABA sup-
presses glucose uptake. In the contralesional motor cortex,
Figure 1. A Reversible MAO-B Inhibitor Reverses Diaschisis in the Motor Cortex in a Capsular Infarct Model
(A) Schematic diagram of the capsular infarct model and timeline of experiments.
(B) Representative H&E-, GFAP-, and neurofilament-stained sections of internal capsule.
(C) FDG-microPET images of sham, stroke, and stroke with KDS2010 treatment.
(D) Cortical diaschisis volume (F4, 50 = 121.1, p < 0.001).
(E) Time-dependent change of NMA in motor cortex (F6, 75 = 6.423, p < 0.001).
(F) Biosynthetic mechanism of GABA through MAO-B in astrocytes.
N refers to the number of animals studied. For all panels, mean ± SEM, assessed using repeated-measures (RM) two-way ANOVA with Bonferroni test (*p < 0.05
and ***p < 0.001; ns, non-significant).
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however, we could not observe alteration of astrocytic GABA or
a correlation between astrocytic GABA and glucose uptake (Fig-
ures 2G–2K). In addition, KDS2010 treatment did not cause any
alteration of morphology and GABA level of astrocytes in sham-
operated animals (Figures S3C–S3H). These results indicate that
cortical hypometabolism in the ipsilesional motor cortex
following capsular infarct requires elevated astrocytic GABA
produced in a MAO-B-dependent manner.
To directly test if reactive astrocytes excessively contain and
release GABA at the single-cell level, we used the sniffer-patch
technique with a biosensor for GABA to detect the release of
GABA from an acutely dissociated astrocyte from the diaschisis
region (Figure 3A), as previously described (Jo et al., 2014).
Among the acutely dissociated cells from rat cortical tissues, a
distinct population of GFAP-positive astrocytes (10.4%) was de-
tected, while almost no neurons (0.04%) were detected (Fig-
ure S4A). The small proportion of GFAP-positive astrocytes
among the whole acutely dissociated cells could be due to the
low expression of GFAP in cortical astrocytes, as revealed by
recent transcriptomic studies (Batiuk et al., 2020; Bayraktar
et al., 2020), and this possibility should be tested in future inves-
tigations. The acutely dissociated cells were stimulated by pres-
sure application of TFLLR, which is a peptide agonist of prote-
ase-activated receptor 1 (PAR1). Because only astrocytes, but
not neurons, express PAR1 in the cortex, TFLLR has been re-
ported to cause Ca2+ increase and transmitter release from as-
trocytes, but not neurons (Lee et al., 2007). We confirmed that
a certain subpopulation of acutely dissociated cells responded
to TFLLR byCa2+ flux analysis using flow cytometry (Figure S4B),
indicating the presence of functional astrocytes. We found that
TFLLR caused a marked release of GABA from cortical astro-
cytes of the stroke rats, while GABA release was rarely observed
in astrocytes in sham-operated rats (Figures 3B–3D). Neverthe-
less, it is still unclear that the GABA response is mediated by as-
trocytes, and it could bemediated by the 90% of GFAP-negative
cells. Overall, these findings support our findings that reactive
astrocytes in the diaschisis region contain and release an exces-
sive amount of GABA, which can be readily released upon Ca2+
increase.
Excessive Tonic Inhibition by Aberrant Astrocytic GABA
We next asked whether excessive astrocytic GABA escalates
the tonic inhibition of cortical pyramidal neurons in the diaschisis
region. We performed whole-cell patch-clamp recordings from
the pyramidal neurons in layer 2/3 of the ipsilesional motor cor-
tex, where diaschisis was pre-identified by FDG-microPET. We
measured GABAA receptor-mediated currents in the presence
of the ionotropic glutamate receptor antagonists APV (50 mM)
and CNQX (20 mM), as described previously (Lee et al., 2010)
(Figure 3E). We found that the tonic GABA current, revealed by
treatment with the GABAA receptor antagonist bicuculline
(50 mM), was dramatically increased in the ipsilesional motor cor-
tex of stroke-operated animals, which was successfully restored
to the normal level by KDS2010 treatment (Figures 3F and 3G).
On the other hand, we could not find any significant change in
the frequency and amplitude of spontaneous inhibitory postsyn-
aptic currents (sIPSCs) in all conditions (Figures 3H and 3L), sug-
gesting that inhibitory action by neuronal phasic GABA was not
altered. In the contralesional motor cortex, both tonic and phasic
GABA currents were not altered (Figures 3J–3N). In addition, we
found that excessive tonic GABA in the diaschisis region was
attributed neither to increased expression of GABAARa5 nor
dysfunction of GAT-mediated GABA uptake (Figures S4C–
S4J). Taken together, aberrant GABA from reactive astrocytes
tonically inhibits the excitability of neighboring neurons in the ip-
silesional motor cortex of the capsular infarct model, ultimately
leading to cortical glucose hypometabolism.
Astrocytic GABA Is Necessary and Sufficient for
Hypometabolism
We have demonstrated that MAO-B inhibition by systemic
administration of KDS2010 reduced the extent and volume of di-
aschisis (Figure 1). To directly identify the cell type and region
specificity of MAO-B’s contribution to diaschisis, we performed
astrocyte-specific gene silencing of MAO-B by injecting a
mixture of AAV-GFAP-Cre-mCherry and lentivirus carrying
pSico-MAO-B-shRNA-GFP (or pSico-scrambled-shRNA-GFP
for control) into the motor cortex, where diaschisis is expected
to be generated by a stroke operation (Figures 4A, S5A, and
S5B). FDG-microPET revealed that subcortical stroke-induced
cortical hypometabolism in the motor cortex was significantly
decreased by astrocyte-specific gene silencing of MAO-B in
the motor cortex, while scrambled short hairpin RNA (shRNA) in-
jection did not rescue from hypometabolism (Figures 4B–4D).
These findings indicate that astrocytic MAO-B in the motor cor-
tex is necessary for the development of cortical hypometabo-
lism. This astrocytic MAO-B-dependent reversal of diaschisis
was associated with reduced astrocytic reactivity and GABA
production (Figures S5C–S5F) and restored tonic GABA current,
but not phasic GABA in the same gene-silenced region (Figures
4E–4H). In addition, astrocyte-specific gene silencing of Bestro-
phin 1 (Best1) (Figures S5G and S5H), a Ca2+-activated anion
channel that is the major GABA-releasing pathway in astrocytes
(Jo et al., 2014; Lee et al., 2010; Oh and Lee, 2017), significantly
Figure 2. MAO-B-Dependent Excessive Astrocytic GABA Was Observed in Diaschisis
(A) Timeline of experiments and primary motor cortex (M1) as the region of interest (ROI).
(B and H) Representative confocal images of GFAP, GABA, and NeuN (n = 3, 5, and 7 for sham, stroke, and stroke + KDS groups, respectively).
(C and I) Representative three-dimensional (3D)-rendered astrocytes using Imaris 9.0.
(D and J) Ramification index of astrocytes (D, F2, 92 = 20.89, p < 0.001; J, F2, 77 = 1,124, p = 0.330).
(E and K) GFAP intensity (E, F2, 27 = 13.12, p < 0.001; K, F2, 28 = 1.103, p = 0.346).
(F and L) GABA intensity in GFAP-positive astrocytes (F, F2, 300 = 19.54, p < 0.001; L, H = 14.93, p = 0.0006).
(G and M) Linear regression of astrocytic GABA and NMA (G, F1, 13 = 6.295; M, F1, 14 = 0.7156).
Every point represents one animal. The number on each bar refers to the number of cells analyzed. N refers to the number of animals studied. For all panels, mean
± SEM, assessed using one-way ANOVA with Tukey test (D–F and J–L) or linear regression (G and M) (*p < 0.05, **p < 0.01, and ***p < 0.001; ns, non-significant).




Figure 3. Pyramidal Neurons in Diaschisis Are Tonically Inhibited by Excessive Astrocytic GABA
(A) Schematic diagram of acute dissociation of astrocytes from motor cortex and sniffer patch.
(B) Representative traces of GABACR-mediated inward currents. Inset, GABA (100 mM)-induced inward currents (n = 3 for each group).
(C) Peak amplitudes of GABACR-mediated currents normalized to full activation (F2, 33 = 6.849, p = 0.003).
(D) Proportion of GABA-releasing astrocytes.
(E and J) Ipsilateral (E) or contralateral (J) motor cortex as ROIs and representative cell image of whole-cell patch clamp.
(F and K) Representative trace of GABAAR-mediated currents (n = 3 for each group).
(G and L) Tonic GABA current (G, F2, 21 = 14.34, p < 0.001; L, F2, 21 = 0.04737, p = 0.954).
(H and M) Amplitude of sIPSC (H, F2, 19 = 0.8124, p = 0.459; M, F2, 19 = 0.06969, p = 0.933).
(I and N) Frequency of sIPSC (I, F2, 19 = 2.519, p = 0.107; N, F2, 19 = 0.06894, p = 0.514).
The number on each bar refers to the number of cells analyzed. N refers to the number of animals studied. For all panels, mean ± SEM, assessed using one-way
ANOVA with Tukey test (*p < 0.05, **p < 0.01, and ***p < 0.001; ns, non-significant).




attenuated the extent and volume of diaschisis (Figures 4B–4D)
and excessive tonic GABA current (Figures 4E–4H). Taken
together, our results indicate that MAO-B-dependent GABA,
which is released through the Best1 channel from astrocytes,
in the motor cortex is necessary for development of glucose
hypometabolism.
We next tested if astrocytic GABA is sufficient to induce dia-
schisis-like glucose hypometabolism. Therefore, we aimed to
determine whether reduction of metabolic rate can be caused
by forcing astrocytic GABA synthesis by directly injecting putres-
cine, the precursormetabolite for GABA production in astrocytes
(Figure 1F), into M1 (Figure S6A). We found that putrescine infu-
sion significantly reducedmetabolic rate on FDG-microPET (Fig-
ures S6B and S6C) and significantly increased astrocytic GABA
and reactivity (Figures S6D–S6F). Furthermore, on the basis of
previous reports that reactive astrocytes aberrantly synthesize
GABA (Jo et al., 2014), we indirectly increased astrocytic
GABA by injecting adeno-GFAP-GFP virus into the same brain
region to induce astrogliosis (Figure 5A), as previously described
(Woo et al., 2017). We observed marked glucose hypometabo-
lism near the injection site (Figures 5B and 5C), with an appear-
ance of numerous reactive astrocytes with increased GABA level
(Figures 5D–5F), whereas saline injection induced neither reac-
tive astrocytes nor hypometabolism. Next, we investigated
whether MAO-B and tonic GABA are indeed critical for glucose
hypometabolism with KDS2010 and L655,708. We orally treated
the adenovirus-injected rats with KDS2010 for 7 days to block
astrocytic GABA synthesis and found that the generation of
glucose metabolic depression was significantly prevented by
KDS2010 treatment (Figures 5G–5J), indicating the critical role
of MAO-B in glucose hypometabolism. Unlike KDS2010,
L655,708 was intraperitoneally administered only once to the
Figure 4. Astrocytic GABA Is Necessary for Diaschisis Formation
(A) Schematic diagram of virus injection and timeline of experiments.
(B) FDG-microPET images of scrambled-, MAO-B-shRNA-, or Best1-shRNA-injected stroke-operated rats.
(C) NMA changes after stroke operations (F2, 19 = 10.20, p = 0.001).
(D) Cortical diaschisis volume (F2, 19 = 156.3, p < 0.001).
(E) Representative traces of GABAAR-mediated currents (n = 3, 3, and 4 for scrambled, MAO-B, and Best1-shRNA groups).
(F) Tonic GABA current (F2, 22 = 4.552, p = 0.022).
(G and H) Amplitude (F2, 22 = 2.157, p = 0.140) (G) and frequency (F2, 22 = 0.7075, p = 0.5037) (H) of sIPSC.
The number on each bar refers to the number of animals (C and D) or cells (F–H) analyzed. N refers to the number of animals studied. For all panels, mean ± SEM,
assessed using RM two-way ANOVA with Bonferroni test (C) or one-way ANOVA with Dunnett test (F–H) (*p < 0.05, **p < 0.01, and ***p < 0.001; ns, non-sig-
nificant).




rats in which glucose hypometabolism was already confirmed,
because the GABAARa5 inhibition can instantly block extrasy-
naptic GABA signaling. We found that glucose hypometabolism
was also significantly reversed by L655,708 treatment (Figures
5K–5N), indicating the critical role of extrasynaptic GABA in
glucose hypometabolism. Taken together, these findings indi-
cate that MAO-B-mediated astrocytic GABA, which binds to ex-
trasynaptic GABAARa5 of neighboring neurons, is sufficient to
induce diaschisis-like glucose hypometabolism.
Astrogliosis in the diaschisis region, which is distant from the
original site of infarct in the internal capsule, could be attributed
to retrograde atrophy of the motor neurons caused by massive
collapse of axons of the corticospinal tract (Figure 1B). We
confirmed the degenerative signs of soma, dendrites, and axons
Figure 5. Astrocytic GABA Is Sufficient for Diaschisis-like Hypometabolism
(A) Timeline of adenovirus injection and microPET.
(B) FDG-microPET images after adeno-GFAP-GFP virus injection.
(C) NMA change (F1, 14 = 42.04, p < 0.001).
(D) Representative confocal images of GFAP, GABA, and NeuN (n = 5 for each group).
(E) GFAP-positive area (t8 = 2.406, p = 0.0427; one image was analyzed from each animal).
(F) GABA intensity in GFAP-positive astrocytes (t90 = 10.13, p < 0.001).
(G and K) Timelines of experiments for treating adeno-GFAP-GFP virus-injected rats with KDS2010 (G) or L655,708 (K).
(H and L) FDG-microPET images with or without KDS2010 (H) or L655,708 treatment (L).
(I and M) Quantification of volume of cortex with glucose hypometabolism after KDS2010 treatment (I) or L655,708 treatment (M). KDS2010 inhibited the gen-
eration of glucose hypometabolism; L655,708 reversed the glucose hypometabolism.
(J and N) NMA change after adeno-GFAP-GFP virus injection with or without drug treatment (J, F1, 10 = 18.94, p = 0.001; N, F2, 20 = 2.86, p = 0.081).
The number on each bar refers to the number of animals (C), images (E), or cells (F) analyzed. N refers to the number of animals studied. For all panels, mean ±
SEM, assessed using RM two-way ANOVAwith Bonferroni test (C, J, and N) or two-tailed Student’s t test (E and F) (*p < 0.05, **p < 0.01, and ***p < 0.001; ns, non-
significant).
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as well as decreased synapse numbers in the diaschisis region
using electron microscopy (Figures S7A–S7F), without any alter-
ation of the size of soma (Figures S7G–S7I). It is possible that this
ultrastructural atrophy of damagedmotor neurons is the cause of
astrogliosis and aberrant astrocytic GABA synthesis, leading to
tonic inhibition of the neighboring motor neurons and hypome-
tabolism (Figure 7). This possibility needs to be validated in the
future.
MAO-B Inhibition Facilitates Rehabilitation-Aided Post-
stroke Recovery
A recent study showed that motor deficits following cortical
stroke are mitigated by reducing GABAA-mediated tonic inhibi-
tion (Clarkson et al., 2010), which we have revealed as the cause
of the cortical hypometabolism in the capsular infarct model.
Coincidently, the appearance of diaschisis is reported to be
inversely correlated with recovery rate of stroke patients (Seitz
et al., 1999; Takasawa et al., 2002). However, whether and
how diaschisis contributes to post-stroke motor recovery from
white matter stroke is unknown. To test if cortical hypometabo-
lism in the diaschisis region impedes motor recovery following
stroke, we treated the stroke-operated animals with KDS2010
and assessed the fine motor function of the contralesional fore-
limb by performing a single-pellet reaching task (SPRT) (Fig-
ure 6A). Contrary to our expectation, severe post-stroke motor
deficits were not recovered by KDS2010 treatment alone (Fig-
ures 6B and 6C). A daily rehabilitation of 20 min SPRT training
also did not recover motor function in this stroke model (Figures
6B and 6C), consistent with a previous study (Kim et al., 2016).
Surprisingly, motor deficits were dramatically recovered when
KDS2010 treatment was combined with rehabilitation (73% to
sham group; Figures 6B and 6C). This trend was similarly
observed in the cylinder test, which was used to assess general
motor function (77% to sham group by combined treatment; Fig-
ures 6D and 6E). Consistent with behavioral recovery, we found
that the combination of KDS2010 and rehabilitation significantly
reduced cortical diaschisis volume and recovered reduced NMA
(Figures 6F–6H). Diaschisis volume showed a significantly nega-
tive correlation with SPRT score (Figure 6I), while NMA showed a
significantly positive correlation with SPRT score (Figure 6J).
These findings indicate that the severity (i.e., extent and magni-
tude) of hypometabolism is tightly correlatedwith behavioral out-
comes. Moreover, a lesion study with a high concentration
(100 mM) of putrescine injection demonstrated that the brain
region of glucose hypometabolism (i.e., motor cortex) is directly
linked to motor function in the cylinder test and SPRT (Figures
S6I–S6L). The most distinguishing feature of combined therapy
was the faster reduction of diaschisis volume compared with
rehabilitation or KDS2010 alone (Figure 6K). Taken together,
reducing the severity of cortical hypometabolism by KDS2010
can significantly facilitate rehabilitation-aided functional recov-
ery after stroke.
DISCUSSION
In this study, we have delineated the molecular and cellular
mechanism of cortical hypometabolism in a subcortical stroke
model and further established that reducing the astrocytic
GABA synthesis by a reversible MAO-B inhibitor facilitates reha-
bilitation-aided motor recovery from stroke, providing a prom-
ising therapeutic strategy for post-stroke recovery. Our study
highlights that a capsular infarct causes retrograde atrophy in
the sensorimotor cortex, leading to a MAO-B-mediated exces-
sive GABA production from reactive astrocytes (Figure 7). The
tonic release of excessive GABA from reactive astrocytes via
the Best1 channel strongly inhibits neighboring neuronal activity,
which results in glucose hypometabolism (i.e., diaschisis).
Furthermore, pharmacological blockade of astrocytic GABA
synthesis significantly reduces the extent and volume of diaschi-
sis and facilitates rehabilitation-aided functional recovery
(Figure 7).
How can MAO-B inhibition cause functional recovery after
white matter stroke? Astrocytic GABA-mediated diaschisis can
exert a powerful brake on rehabilitation-mediated enhancement
of neuronal activity, which could have induced a reorganization
of recovery circuits. Indeed, we observed that combination ther-
apy with rehabilitation andMAO-B inhibition caused a prominent
and sustained increase in FDG signals in some subcortical struc-
tures, including medial thalamic nuclei, red nucleus, periaque-
ductal gray, and mesencephalic reticular formation, whereas
rehabilitation alone or MAO-B inhibition caused only a marginal
effect in those regions (Figure S1). These findings raise the pos-
sibility that combined therapy causes a reorganization of recov-
ery circuits, which might participate in post-stroke recovery in
the capsular stroke model (Figure 7). This exciting possibility
awaits future investigations.
Overall, our findings are consistent with a previous clinical
study demonstrating a possible beneficial effect of selegiline,
Figure 6. Combined Therapy of KDS2010 Treatment and Rehabilitation Recovers Post-stroke Motor Deficits
(A) Timeline of behavioral experiments and groups categorized by interventions.
(B) Schematic diagram of SPRT and SPRT score change by each intervention (F24, 252 = 29.9, p < 0.001).
(C) SPRT score at PL22 (F4, 42 = 69.66, p < 0.001).
(D) Left: schematic diagram of cylinder test. Right: ratio of impaired forelimb use assessed by cylinder test (F24, 252 = 6.956, p < 0.001).
(E) Ratio of impaired forelimb use at PL22 (F4, 42 = 16.35, p < 0.001).
(F) FDG-microPET images of sham, stroke, and stroke with KDS2010 treatment.
(G) Quantification of cortical diaschisis volume (F4, 48 = 120.0, p < 0.001).
(H) Time-dependent change of NMA in motor cortex (F6, 72 = 2.101, p = 0.064).
(I) Negative correlation between cortical diaschisis volume and SPRT score (F1, 25 = 15.42).
(J) Positive correlation between NMA of diaschisis region and SPRT score (F1, 25 = 18.92).
(K) Time-dependent change of normalized cortical diaschisis volume (F6, 64 = 82.83, p < 0.001).
The number on each bar refers to the number of animals analyzed. N refers to the number of animals studied. For all panels, mean ± SEM, assessed using one-
way ANOVA with Tukey test (C and E) or RM two-way ANOVA with Bonferroni test (all other panels) (*p < 0.05, **p < 0.01, and ***p < 0.001; ns, non-significant).




an irreversible MAO-B inhibitor, on recovery after stroke (Sive-
nius et al., 2001). However, in that study, the therapeutic effect
of selegiline did not reach statistical significance (Sivenius
et al., 2001). This is most likely due to the short-lived action of se-
legiline (Jo et al., 2014). Very recently, we demonstrated that pro-
longed treatment with selegiline fails to reduce aberrant astro-
cytic GABA because of compensatory upregulation of
alternative GABA-synthetic enzymes in astrocytes, which could
be attributed to the irreversibility of selegiline (Park et al., 2019).
To overcome the shortcomings of irreversible MAO-B inhibitors
such as selegiline, we have recently developed KDS2010, with
high selectivity over MAO-A and reversibility with no significant
Figure 7. Schematic Diagram of Mechanism of Diaschisis through Excessive Tonic Inhibition Mediated by Astrocytic GABA and the Ther-
apeutic Mechanism of Combination of KDS2010 and Rehabilitation




toxicity (Park et al., 2019). Our present study suggests KDS2010
as an effective replacement of selegiline for treatment of
capsular stroke. Furthermore, KDS2010 is proved to possess
an excellent pharmacokinetic profile, with high bioavailability
(>100%), high blood-brain barrier permeability, and high target
specificity in the central nervous system (Park et al., 2019). On
the basis of these superior drug-like properties, pharmacological
profiles, and potent therapeutic effect in the capsular infarct
model, we propose KDS2010 as a next-generation drug candi-
date for capsular stroke.
In addition to producing GABA in astrocytes, MAO-B has long
been believed to degrade dopamine and produce hydrogen
peroxide. Therefore, the effect of KDS2010 on relieving diaschisis
and post-stroke functional recovery in capsular infarct model
might be attributed to inhibiting dopamine degradation, hydrogen
peroxide production, and/or astrocytic GABA synthesis. In terms
of dopamine degradation, numerous reports have suggested that
the role of MAO-B in dopamine degradation has been exagger-
ated and have cast doubt on the role of MAO-B in dopamine
degradation. For example, several studies demonstrated no
change in extracellular dopamine level in MAO-B-deficient mice
(Fornai et al., 1999) and selegiline-treated mice (Lamensdorf
et al., 1996). These reports raise the possibility that MAO-A is
more likely to be engaged in dopamine degradation than MAO-
B. On the other hand, MAO-B is also well known as a producer
of hydrogen peroxide, andMAO-B inhibition can reduce oxidative
stress, raising the possibility that the therapeutic effect of
KDS2010 could be attributed to a reduction of oxidative stress.
However, we have demonstrated that the diaschisis is reversed
by a treatment with L655,708, an inverse agonist of GABAARa5,
suggesting that KDS2010’s effect is more likely due to MAO-B’s
action onGABAproduction rather thanH2O2 production. Our find-
ings suggest that MAO-B-dependent astrocytic GABA is the key
molecule for the generation and maintenance of the diaschisis.
On the other hand, we cannot completely rule out the possibility
that functional recovery after stroke by KDS2010 is due to a
reduction of MAO-B-dependent oxidative stress. This remaining
possibility awaits further investigations.
The role of reactive astrocytes in the excitation/inhibition (E/I)
balance has been controversial. Several studies have demon-
strated that reactive astrocytes exhibit impaired function of
glutamate uptake, causing neuronal hyperexcitability and spon-
taneous epileptic seizures (Ortinski et al., 2010; Robel et al.,
2015). On the other hand, reactive astrocytes have been demon-
strated to produce and release aberrantly excessive GABA to
strongly inhibit neuronal excitability (Chun et al., 2018; Jo et al.,
2014; Kim et al., 2017; Park et al., 2019; Wu et al., 2014). Reac-
tive astrocytes might exhibit either of the two paradoxical char-
acteristics or both, depending on the degree of reactivity, brain
regions, or disease-specific local environment. We propose
that astrogliosis in the epileptic brain and reactive astrocytes in
the diaschisis region or in the Alzheimer’s disease brain are
distinct: the former might exhibit impaired glutamate uptake
but less increased GABA production, while the latter might
exhibit a greater increase in GABA production but less impaired
glutamate uptake. Such a difference in glutamate uptake and
GABA production should differentially affect the E/I balance. In
the present study of a capsular stroke model, astrocytes in the
motor cortex became reactive and exhibited a greater increase
in GABA production, causing neuronal metabolic depression
rather than neuronal hyperactivity.
Diaschisis, manifested by depression of blood flow and meta-
bolism in a distant area following a focal brain injury, has been
previously proposed as a prognostic marker for the likelihood
of functional recovery in stroke patients (Takasawa et al.,
2002). However, this proposal has not been properly validated.
Our study provides the mechanistic insights for the proposed
use of diaschisis-induced regional metabolic depression as a
prognostic marker for functional recovery after capsular stroke.
This was evidenced by the observed negative correlation be-
tween the extent of diaschisis-induced glucose hypometabolism
and post-stroke functional recovery (Figure 7I). More important,
we provide a potent therapeutic tool to actively reduce the extent
of diaschisis, thus facilitating functional recovery after stroke.We
hope that our therapeutic strategy ofMAO-B inhibition by revers-
ible MAO-B inhibitors for post-stroke recovery will be translated
into clinical trials in the near future.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:




B Data and Code Availability
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
d METHOD DETAILS
B Photothrombotic capsular infarction
B MicroPET Image acquisition and processing
B Histological examination
B Sniffer patch with acutely dissociated astrocytes
B Flow Cytometry with acutely dissociated astrocytes
B Astrocyte phenotyping
B Calcium flux measurement
B Whole-cell patch-clamp
B Electron microcopy and toluidine blue staining
B Drug administration
B Measurements of MAO-B enzyme activity
B Behavioral testing
B Preparation and injection of putrescine and viruses
B Quantitative real-time RT-PCR




Supplemental Information can be found online at https://doi.org/10.1016/j.
celrep.2020.107861.
ACKNOWLEDGMENTS
This work is supported by the Creative Research Initiative Program
(2015R1A3A2066619) funded by National Research Foundation (NRF) of




Korea and Institute for Basic Science (IBS), Center for Cognition and Sociality
(IBS-R001-D2) to C.J.L.; Basic Science Research Program funded by NRF of
Korea (NRF-2016R1A2B3009660) and Biomedical Integrated Technology
Research Project through a grant provided by GIST in 2017 to H.-I.K.; and
KIST institutional program (Project No. 2E30180) through Korea Institute of
Science and Technology funded by the Ministry of Science and ICT of Korea
to M.-H.N.
AUTHOR CONTRIBUTIONS
H.-I.K., C.J.L., M.Y., and M.-H.N. conceived and designed the research.
J.-Y.P., R.G.K., and H.S. performed surgical procedures. J.C., D.-H.K, S.L.,
and H.K. performed PET. M.-H.N., J.L., and W.W. performed immunohisto-
chemistry. M.-H.N., J.W., and S.-J.O. performed electrophysiology. J.W.C.,
E.K.P., and K.D.P. synthesized the chemicals. H.-S.K. and M.-C.L. performed
electron microscopy. H.J. and W.W. performed fluorescence-activated cell
sorting. M.-H.N., J.C., H.-I.K., and C.J.L. wrote the manuscript. All authors
provided ongoing critical review of results and commented on the manuscript.
DECLARATION OF INTERESTS
M.-H.N., J.C., J.-Y.P., S.-J.O., K.D.P., C.J.L., and H.-I.K. have a registered
patent in the Republic of Korea on the therapeutic potential of KDS2010 for
post-stroke recovery (KR-10-2005019) and the competing interests for the
commercial development of KDS2010.
Received: July 18, 2019
Revised: May 18, 2020
Accepted: June 12, 2020
Published: July 7, 2020; corrected online: July 15, 2020
REFERENCES
Badan, I., Buchhold, B., Hamm, A., Gratz, M., Walker, L.C., Platt, D., Kessler,
Ch., and Popa-Wagner, A. (2003). Accelerated glial reactivity to stroke in aged
rats correlates with reduced functional recovery. J. Cereb. Blood Flow Metab.
23, 845–854.
Batiuk, M.Y., Martirosyan, A., Wahis, J., de Vin, F., Marneffe, C., Kusserow, C.,
Koeppen, J., Viana, J.F., Oliveira, J.F., Voet, T., et al. (2020). Identification of
region-specific astrocyte subtypes at single cell resolution. Nat. Commun.
11, 1220.
Bayraktar, O.A., Bartels, T., Holmqvist, S., Kleshchevnikov, V.,Martirosyan, A.,
Polioudakis, D., Ben Haim, L., Young, A.M.H., Batiuk, M.Y., Prakash, K., et al.
(2020). Astrocyte layers in themammalian cerebral cortex revealed by a single-
cell in situ transcriptomic map. Nat. Neurosci. 23, 500–509.
Bi, F., Huang, C., Tong, J., Qiu, G., Huang, B., Wu, Q., Li, F., Xu, Z., Bowser, R.,
Xia, X.G., and Zhou, H. (2013). Reactive astrocytes secrete lcn2 to promote
neuron death. Proc. Natl. Acad. Sci. U S A 110, 4069–4074.
Burda, J.E., and Sofroniew, M.V. (2014). Reactive gliosis and the multicellular
response to CNS damage and disease. Neuron 81, 229–248.
Carrera, E., and Tononi, G. (2014). Diaschisis: past, present, future. Brain 137,
2408–2422.
Chu, W.J., Mason, G.F., Pan, J.W., Hetherington, H.P., Liu, H.G., San Pedro,
E.C., and Mountz, J.M. (2002). Regional cerebral blood flow and magnetic
resonance spectroscopic imaging findings in diaschisis from stroke. Stroke
33, 1243–1248.
Chun, H., An, H., Lim, J., Woo, J., Lee, J., Ryu, H., and Lee, C.J. (2018). Astro-
cytic proBDNF and tonic GABA distinguish active versus reactive astrocytes in
hippocampus. Exp. Neurobiol. 27, 155–170.
Clarkson, A.N., Huang, B.S., Macisaac, S.E., Mody, I., and Carmichael, S.T.
(2010). Reducing excessive GABA-mediated tonic inhibition promotes func-
tional recovery after stroke. Nature 468, 305–309.
Cox, R.W. (1996). AFNI: software for analysis and visualization of functional
magnetic resonance neuroimages. Comput. Biomed. Res. 29, 162–173.
Endoh,M., Maiese, K., andWagner, J. (1994). Expression of the inducible form
of nitric oxide synthase by reactive astrocytes after transient global ischemia.
Brain Res. 651, 92–100.
Finger, S., Koehler, P.J., and Jagella, C. (2004). The Monakow concept of dia-
schisis: origins and perspectives. Arch. Neurol. 61, 283–288.
Fornai, F., Chen, K., Giorgi, F.S., Gesi, M., Alessandri, M.G., and Shih, J.C.
(1999). Striatal dopamine metabolism in monoamine oxidase B-deficient
mice: a brain dialysis study. J. Neurochem. 73, 2434–2440.
Garbuzova-Davis, S., Rodrigues, M.C., Hernandez-Ontiveros, D.G., Tajiri, N.,
Frisina-Deyo, A., Boffeli, S.M., Abraham, J.V., Pabon, M., Wagner, A., Ishi-
kawa, H., et al. (2013). Blood-brain barrier alterations provide evidence of sub-
acute diaschisis in an ischemic stroke rat model. PLoS ONE 8, e63553.
Gharbawie, O.A., Gonzalez, C.L., and Whishaw, I.Q. (2005). Skilled reaching
impairments from the lateral frontal cortex component of middle cerebral ar-
tery stroke: a qualitative and quantitative comparison to focal motor cortex le-
sions in rats. Behav. Brain Res. 156, 125–137.
Heo, J.Y., Nam, M.H., Yoon, H.H., Kim, J., Hwang, Y.J., Won, W., Woo, D.H.,
Lee, J.A., Park, H.J., Jo, S., et al. (2020). Aberrant tonic inhibition of dopami-
nergic neuronal activity causes motor symptoms in animal models of Parkin-
son’s disease. Curr. Biol. 30, 276–291.e9.
Hsu, J.E., and Jones, T.A. (2005). Time-sensitive enhancement of motor
learning with the less-affected forelimb after unilateral sensorimotor cortex le-
sions in rats. Eur. J. Neurosci. 22, 2069–2080.
Hua, Y., Schallert, T., Keep, R.F., Wu, J., Hoff, J.T., and Xi, G. (2002). Behav-
ioral tests after intracerebral hemorrhage in the rat. Stroke 33, 2478–2484.
Jo, S., Yarishkin, O., Hwang, Y.J., Chun, Y.E., Park, M., Woo, D.H., Bae, J.Y.,
Kim, T., Lee, J., Chun, H., et al. (2014). GABA from reactive astrocytes impairs
memory in mouse models of Alzheimer’s disease. Nat. Med. 20, 886–896.
Kim, H.S., Kim, D., Kim, R.G., Kim, J.M., Chung, E., Neto, P.R., Lee, M.C., and
Kim, H.I. (2014). A rat model of photothrombotic capsular infarct with amarked
motor deficit: a behavioral, histologic, and microPET study. J. Cereb. Blood
Flow Metab. 34, 683–689.
Kim, D., Kim, R.G., Kim, H.S., Kim, J.M., Jun, S.C., Lee, B., Jo, H.J., Neto, P.R.,
Lee, M.C., and Kim, H.I. (2015). Longitudinal changes in resting-state brain ac-
tivity in a capsular infarct model. J. Cereb. Blood Flow Metab. 35, 882.
Kim, R.G., Cho, J., Ree, J., Kim, H.S., Rosa-Neto, P., Kim, J.M., Lee, M.C., and
Kim, H.I. (2016). Sensory-parietal cortical stimulation improvesmotor recovery
in severe capsular infarct. J. Cereb. Blood Flow Metab. 36, 2211–2222.
Kim, Y.S., Woo, J., Lee, C.J., and Yoon, B.E. (2017). Decreased glial GABA and
tonic inhibition in cerebellum of mouse model for attention-deficit/hyperactiv-
ity disorder (ADHD). Exp. Neurobiol. 26, 206–212.
Lalo, U., Pankratov, Y., Kirchhoff, F., North, R.A., and Verkhratsky, A. (2006).
NMDA receptors mediate neuron-to-glia signaling in mouse cortical astro-
cytes. J. Neurosci. 26, 2673–2683.
Lalo, U., Palygin, O., North, R.A., Verkhratsky, A., and Pankratov, Y. (2011).
Age-dependent remodelling of ionotropic signalling in cortical astroglia. Aging
Cell 10, 392–402.
Lalo, U., Palygin, O., Rasooli-Nejad, S., Andrew, J., Haydon, P.G., and Pankra-
tov, Y. (2014). Exocytosis of ATP from astrocytes modulates phasic and tonic
inhibition in the neocortex. PLoS Biol. 12, e1001747.
Lamensdorf, I., Youdim, M.B., and Finberg, J.P. (1996). Effect of long-term
treatment with selective monoamine oxidase A and B inhibitors on dopamine
release from rat striatum in vivo. J. Neurochem. 67, 1532–1539.
Lee, C.J., Mannaioni, G., Yuan, H., Woo, D.H., Gingrich, M.B., and Traynelis,
S.F. (2007). Astrocytic control of synaptic NMDA receptors. J. Physiol. 581,
1057–1081.
Lee, Y., Messing, A., Su, M., and Brenner, M. (2008). GFAP promoter elements
required for region-specific and astrocyte-specific expression. Glia 56,
481–493.
Lee, S., Yoon, B.E., Berglund, K., Oh, S.J., Park, H., Shin, H.S., Augustine,
G.J., and Lee, C.J. (2010). Channel-mediated tonic GABA release from glia.
Science 330, 790–796.




Li, Y., Wang, D., Zhang, H., Wang, Y., Wu, P., Zhang, H., Yang, Y., and Huang,
W. (2016). Changes of brain connectivity in the primary motor cortex after
subcortical stroke: a multimodal magnetic resonance imaging study. Medicine
(Baltimore) 95, e2579.
Lundgaard, I., Li, B., Xie, L., Kang, H., Sanggaard, S., Haswell, J.D., Sun, W.,
Goldman, S., Blekot, S., Nielsen, M., et al. (2015). Direct neuronal glucose up-
take heralds activity-dependent increases in cerebral metabolism. Nat. Com-
mun. 6, 6807.
Mucke, L., and Eddleston, M. (1993). Astrocytes in infectious and immune-
mediated diseases of the central nervous system. FASEB J. 7, 1226–1232.
Oh, S.J., and Lee, C.J. (2017). Distribution and function of the Bestrophin-1
(Best1) channel in the brain. Exp. Neurobiol. 26, 113–121.
Ortinski, P.I., Dong, J., Mungenast, A., Yue, C., Takano, H., Watson, D.J., Hay-
don, P.G., and Coulter, D.A. (2010). Selective induction of astrocytic gliosis
generates deficits in neuronal inhibition. Nat. Neurosci. 13, 584–591.
Pandit, S., Neupane, C., Woo, J., Sharma, R., Nam, M.H., Lee, G.S., Yi, M.H.,
Shin, N., Kim, D.W., Cho, H., et al. (2020). Bestrophin1-mediated tonic GABA
release from reactive astrocytes prevents the development of seizure-prone
network in kainate-injected hippocampi. Glia 68, 1065–1080.
Papp, E.A., Leergaard, T.B., Calabrese, E., Johnson, G.A., and Bjaalie, J.G.
(2014). Waxholm space atlas of the Sprague Dawley rat brain. Neuroimage
97, 374–386.
Park, J.-H., Ju, Y., Choi, J.W., Song, H.J., Jang, B.K., Woo, J., Chun, H., Kim,
H.J., Shin, S.J., Yarishkin, O., et al. (2019). Newly developed reversible MAO-B
inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s
disease. Sci. Adv. 5, eaav0316.
Robel, S., Buckingham, S.C., Boni, J.L., Campbell, S.L., Danbolt, N.C., Riede-
mann, T., Sutor, B., and Sontheimer, H. (2015). Reactive astrogliosis causes
the development of spontaneous seizures. J. Neurosci. 35, 3330–3345.
Sacco, S., Marini, C., Totaro, R., Russo, T., Cerone, D., and Carolei, A. (2006).
A population-based study of the incidence and prognosis of lacunar stroke.
Neurology 66, 1335–1338.
Seitz, R.J., Azari, N.P., Knorr, U., Binkofski, F., Herzog, H., and Freund, H.J.
(1999). The role of diaschisis in stroke recovery. Stroke 30, 1844–1850.
Shim, H.S., Park, H.J., Woo, J., Lee, C.J., and Shim, I. (2019). Role of astrocytic
GABAergic system on inflammatory cytokine-induced anxiety-like behavior.
Neuropharmacology 160, 107776.
Sivenius, J., Sarasoja, T., Aaltonen, H., Heinonen, E., Kilkku, O., and Reinikai-
nen, K. (2001). Selegiline treatment facilitates recovery after stroke. Neurore-
habil. Neural Repair 15, 183–190.
Song, H., Park, J.Y., Kim, H.S., Lee, M.C., Kim, Y., and Kim, H.I. (2016). Cir-
cumscribed capsular infarct modeling using a photothrombotic technique.
J. Vis. Exp. (112), 53281.
Song, H., Jung, W., Lee, E., Park, J.Y., Kim, M.S., Lee, M.C., and Kim, H.I.
(2017). Capsular stroke modeling based on somatotopic mapping of motor
fibers. J. Cereb. Blood Flow Metab. 37, 2928–2937.
Takasawa, M., Watanabe, M., Yamamoto, S., Hoshi, T., Sasaki, T., Hashi-
kawa, K., Matsumoto, M., and Kinoshita, N. (2002). Prognostic value of sub-
acute crossed cerebellar diaschisis: single-photon emission CT study in pa-
tients with middle cerebral artery territory infarct. AJNR Am. J. Neuroradiol.
23, 189–193.
Tatsch, K., Koch, W., Linke, R., Poepperl, G., Peters, N., Holtmannspoetter,
M., and Dichgans, M. (2003). Cortical hypometabolism and crossed cerebellar
diaschisis suggest subcortically induced disconnection in CADASIL: an 18F-
FDG PET study. J. Nucl. Med. 44, 862–869.
Woo, J., Im, S.K., Chun, H., Jung, S.Y., Oh, S.J., Choi, N., Lee, C.J., and Hur,
E.M. (2017). Functional characterization of resting and adenovirus-induced
reactive astrocytes in three-dimensional culture. Exp. Neurobiol. 26, 158–167.
Wu, Z., Guo, Z., Gearing, M., and Chen, G. (2014). Tonic inhibition in dentate
gyrus impairs long-term potentiation andmemory in an Alzheimer’s [corrected]
disease model. Nat. Commun. 5, 4159.
Yamashita, Y., Wada, I., Horiba, M., and Sahashi, K. (2016). Influence of cere-
bral white matter lesions on the activities of daily living of older patients with
mild stroke. Geriatr. Gerontol. Int. 16, 942–947.
Yoon, B.E., Woo, J., Chun, Y.E., Chun, H., Jo, S., Bae, J.Y., An, H., Min, J.O.,
Oh, S.J., Han, K.S., et al. (2014). Glial GABA, synthesized by monoamine ox-
idase B, mediates tonic inhibition. J. Physiol. 592, 4951–4968.






REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Chicken anti-GFAP Millipore Cat# ab5541; RRID: AB_177521
Mouse anti-Neurofilament DAKO Cat# M0762; RRID: AB_2314899
Guinea pig anti-GABA Millipore Cat# ab175; RRID: AB_91011
Mouse anti-NeuN Millipore Cat# MAB377; RRID: AB_2298772
Goat anti-Maob Santa Cruz Cat# sc-18401; RRID: AB_2137271
Rabbit anti-PV Swant Cat# PV27; RRID: AB_2631173
Goat anti-LCN2 Abcam Cat# ab31289; RRID: AB_776042
Rabbit anti-Iba1 Wako Cat# 019-19741; RRID: AB_839504
DAPI Pierce Cat# D1306; RRID: AB_2629482
Alexa 488 donkey anti-chicken Jackson ImmunoResearch Cat# 703-545-155, RRID: AB_2340375
Alexa-594 donkey anti-rabbit Jackson ImmunoResearch Cat# 711-585-152, RRID: AB_2340621
Alexa-647 donkey anti-mouse Jackson ImmunoResearch Cat# 715-605-151; RRID: AB_2340863
Alexa-594 donkey anti-guinea pig Jackson ImmunoResearch Cat# 706-585-148; RRID: AB_2340474
Alexa-647 donkey anti-rabbit Jackson ImmunoResearch Cat#; 711-605-152 RRID: AB_2492288
Bacterial and Virus Strains
AAVDJ-GFAP-Cre-mCherry KIST virus facility N/A
Lenti-pSico-MAOB-shRNA-GFP KIST virus facility N/A
Lenti-pSico-scrambled-shRNA-GFP KIST virus facility N/A
Adeno-GFAP-GFP KIST virus facility N/A
Chemicals, Peptides, and Recombinant Proteins
KDS2010 This paper N/A
Putrescine dihydrochloride Sigma aldrich Cat# P7075; CAS: 333-93-7
Rose Bengal Sigma aldrich Cat# 330000; CAS: 632-69-9
L655,708 Sigma aldrich Cat# L9787; CAS: 130477-52-0
Amplex Red Monoamine oxidase Assay Kit Invitrogen Cat# A12214; CAS: N/A
GABA Tocris Cat# 0344; CAS: 56-12-2
D-AP5 Tocris Cat# 0106; CAS: 79055-68-8
CNQX Tocris Cat# 0190; CAS: 115066-14-3
(-)-Bicuculline methobromide Tocris Cat# 0109; CAS: 73604-30-5
NO-711 hydrochloride Sigma aldrich Cat# N142; CAS: 145645-62-1
(S)-SNAP-5114 Sigma aldrich Cat# S1069; CAS: 157604-55-2
Critical Commercial Assays
Amplex Red Monoamine Oxidase Assay Kit Thermo Fisher Scientific Cat#: A12214
Experimental Models: Cell Lines




Mouse: Sprague Dawley rats Taconic Cat# SD-M
Oligonucleotides
MAOB shRNA targeting sequence: AAT CGT AAG ATA
CGA TTC TGG
Jo et al., 2014 N/A
Recombinant DNA
pSicoR-MAOBshRNA-mCherry Jo et al., 2014 N/A
pSicoR-scrambled-shRNA-mCherry Jo et al., 2014 N/A
(Continued on next page)






Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, C. Justin
Lee (cjl@kist.re.kr).
Materials Availability
This study did not generate new unique reagents, plasmids, nor mouse lines.
Data and Code Availability
This study did not generate any code.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal care and handling were performed according to the directives of the Animal Care and Use Committee and institutional guide-
lines of KIST (Seoul, Korea) and GIST (Gwangju, Korea). Experiments were performed on 105 adult male Sprague Dawley rats
(9 weeks old,300 g) including stroke experiment (N = 73) and cortex gliosis-inducing experiment (N = 32). All animals were housed
two per cage in a controlled animal facility with ad libitum access to food and water. The animal care unit was maintained on a 12 h
light–dark cycle (07:00 – 19:00) with controlled temperature (21 ± 1C) and humidity (50%).
Forty-six rats underwent circumscribed photothrombotic stroke lesioning in the posterior limb of the internal capsule (PLIC) and
were randomly allocated into 5 groups based on the rehabilitative training and administration of MAO-B inhibitor (KDS2010): (1)
sham operated group (N = 10, Sham), (2) non-rehabilitation group without KDS2010 treatment (N = 9, Stroke), (3) non-rehabilita-
tion group with KDS2010 (N = 9, Stroke+KDS2010), (4) rehabilitation group without KDS2010 (N = 9, Stroke+rehab), (5) rehabil-
itation group with KDS2010 (N = 9, Stroke+rehab+KDS2010). The proportion of left-handed animals in each group was as follows:
40%, 44%, 33%, 33%, and 56% for sham, stroke, stroke+rehab, stroke+KDS, and stroke+KDS+rehab, respectively. Twenty-two
rats underwent lentivirus carrying MAO-B shRNA (N = 8), Best1-shRNA (N = 8) or scrambled shRNA injection (N = 6) into motor
cortex and stroke lesioning in the PLIC. Thirty-two rats underwent adeno-GFAP-GFP virus injection (N = 8), saline-control (N = 8),
or putrescine injection (N = 8), saline-control (N = 8). Eighteen rats underwent stroke lesioning in the PLIC and treated with
KDS2010 (N = 6), L655,708 (N = 6), or saline (N = 6). Five rats underwent stroke lesioning in the PLIC and sacrificed for electro-
physiology with GABA transporter (GAT) blockers (NO-711 and SNAP-5114). Fifteen rats were underwent stroke lesioning for RT-




Rats underwent photothrombotic capsular stroke lesioning in the PLIC as previously described (Kim et al., 2014; Song et al., 2016).
Briefly, animals were anesthetized with a mixture of ketamine hydrochloride (100 mg/kg) and xylazine (7 mg/kg) and rectal temper-
ature was maintained at 37 ± 0.5C using heating pad. The optic fiber with a core diameter of 62.5 mm and an outer diameter of
125 mmwas stereotaxically inserted into PLIC target (AP =2.0 mm, ML = 3.1 mm from bregma, DV = 7.2 mm from dura). Rose Ben-
gal dye (20 mg/kg) was injected through the tail vein. Then, the target was irradiated for 1.5 minutes using the green laser (3.7mW).
After laser irradiation, the optical fiber was removed and the scalp wound was sutured. After surgery, the animal was treated with
ketoprofen (2 mg/kg, i.m.) for pain control. The sham group underwent the same surgical procedure, except that they received an
injection of 0.9% saline instead of Rose Bengal dye.
Continued
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Minianalysis Synaptosoft http://www.synaptosoft.com/MiniAnalysis/




The stroke operation was validated by the first set of SPRT which was performed 3 days after stroke operation. Normally, the
stroke-operated rats show distinctively impaired motor behavior, while 20%–30% of the rats did not, which is due to improper tar-
geting of light fiber during stroke operation. These animals, which did not show impaired motor behavior 3 days after stroke opera-
tion, were dropped in the following experiments. No animal was excluded from the analysis after behavioral experiments and FDG-
microPET scanning.
MicroPET Image acquisition and processing
Longitudinal microPET scans were performed tomeasure the regional glucosemetabolism before and after lesioning, administration
of KDS2010, and rehabilitative training. Each rat was scanned a total of four times: a baseline scan prior to infarct lesioning (PL 1),
and scans on post-lesion (PL) days 7, 14, and 21. The microPET/CT scanner (Inveon, SiemensMedical Solution) has a transaxial res-
olution of 1.4 mm full width at half maximum and a 12.7 mm field of view. Animals were food-deprived for 12 h before each scan, and
2-deoxy-2-[18F]-fluoro-D-glucose (FDG; 0.1 mCi/100 g) was injected into the tail vein. After a 30-minute uptake period, the animals
were anesthetized with 2% isoflurane and transferred in the scanner. The head was fixed with a customized head holder (Hyosung
Inc.). Vital signs including respiration (50 ± 5 respirations/min), heart rate (280 ± 20 beats/min), and rectal temperature (37.0 ± 1C)
were monitored during scanning procedures (BioVet, m2m Imaging Corp). A 25-min static acquisition and 5-min attenuation-correc-
tion computed tomography scan were performed. The acquired images were reconstructed with the iterative OSEM3D/MAP algo-
rithm. Image analysis was performed with the Analysis of Functional NeuroImages (AFNI) package (Cox, 1996). All acquired images
were automatically co-registered to theMRI template of Sprague Dawley rat brain (Papp et al., 2014), andmanual co-registration was
performed for minor misalignment to the template. Images were normalized to the mean value of the whole brain and spatially
smoothed using a 3-D isotropic Gaussian kernel with 1.2 mm full width at half maximum. MRIcroGL program was used to acquire
the 3-D rendered images (http://www.cabiatl.com/mricrogl/).
To identify the metabolic activity of a specific brain region, we utilized NMA (normalized metabolic activity) which is each voxel’s
standardized uptake value (SUV) of FDG normalized by averaged SUV throughout the whole brain. SUV is the quantity of incorpo-
rated FDG in a specific brain region of each animal.
In addition, microPET scans were performed in the same way for cortex gliosis-inducing experiment. Each rat was scanned twice:
pre-injection and post-injection scans (AAV and putrescine). For AAV injection group, the post-injection scan was done after 2 weeks
of injection, in contrast, the putrescine-injection group was scanned after 2 days. Eight rats which received the injection of saline
instead of AAV or Putrescine and scans were used for control.
For investigating the effect of KDS2010 and L655,708 in adeno-GFAP-GFP-induced decrease in FDG uptake, we also performed
microPET scans. For KDS2010 experiment, each rat was scanned twice: pre-injection (3 days prior to virus injection) and post-injec-
tion scans (7 days after virus injection). For L655,708 experiment, each rat was scanned three times: pre-injection (3 days prior to
virus injection), pre-L655,708 (7 days after virus injection), and post-L655,708 (9 days after virus injection). Scanning and analyses
were performed in a same way as described above.
Histological examination
For immunohistochemistry, animals were anaesthetized with ketamine (100mg/kg), and perfused transcardially with 0.9% saline so-
lution followed by 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS). After post-fixation with 4% paraformaldehyde for
12 h and cryoprotection with 30% sucrose, the brains were coronally sectioned with 30-mm thickness. Sections were stained for he-
matoxylin and eosin (H&E), and immunostained for GFAP, neurofilament-M/H, or Iba1 protein. Primary antibodies were used as
follow: GFAP (1:400, Invitrogen, PA1-9565) and neurofilament (1:600, Dako, M0762). Immunostaining was performed using the
avidin-biotin peroxidase method with the ABC Kit (Vector Laboratories), as previously described (Woo et al., 2017). In brief, antigen
retrieval was conducted by heating the tissue sections at 60C for 5 minutes in sodium citrate buffer, after which the sections were
incubated in a mixture of 3% hydrogen peroxide and 10% methanol for 20 minutes, followed by 10% goat serum for 1 h at room
temperature. The sections were incubated with each primary antibody for 2 h, biotinylated secondary antibody for 20 minutes,
and streptavidin-horseradish peroxidase (Dako Cytomation) for 20 minutes. They were then developed with a chromogenic solution
of diaminobenzidine and counterstained with hematoxylin to visualize cell nuclei. Known positive and negative tissues were used as
controls.
For immunofluorescence, 30 mm-thick cryosections were incubated for 1 h in a blocking solution (0.3%Triton-X, 3%donkey serum
in 0.1 M PBS) and then immunostained with a mixture of primary antibodies in a blocking solution at 4C on a shaker overnight. After
washing in PBS 3 times, sections were incubated with corresponding fluorescent secondary antibodies for 1.5 h and then washed
with PBS 3 times. If needed, DAPI (Pierce, 1:3,000) was stained during the second washing step. Finally, sections were mounted with
fluorescent mounting medium (Dako) and dried. A series of fluorescent images were obtained with A1 Nikon confocal microscope,
and 30-mmZ stack images in 3-mm steps were processed for further analysis using NIS-Elements (Nikon) software and ImageJ (NIH)
program. The primary antibodies used for fluorescent immunostaining were as follows: chicken anti-GFAP (1:500; Millipore ab5541),
guinea pig anti-GABA (1:200; Millipore ab175), mouse anti-NeuN (1:1000; Millipore MAB377), goat anti-MAOB (1:100; Santa cruz sc-
18401), rabbit anti-PV (1:500; Swant PV27), goat anti-LCN2 (1:50; Abcam ab31289), and rabbit anti-Iba1 (1:200; Wako 019-19741).
Fluorescent secondary antibodies were purchased from Invitrogen or Jackson ImmunoResearch and used in 1:500 dilutions.




Sniffer patch with acutely dissociated astrocytes
Sniffer patch was performed as described with a slight modification (Jo et al., 2014). The quickly excised brain was submerged in
ice-cold cutting solution that contained (in mM): 250 sucrose, 26 NaHCO3, 10 d-(+)-glucose, 4 MgCl2, 3 myo-inositol, 2.5 KCl, 2 so-
dium pyruvate, 1.25 NaH2PO4, 0.5 ascorbic acid, 0.1 CaCl2 and 1 kynurenic acid, pH 7.4. All solution was gassed with 95%O2 – 5%
CO2. The brain regions containing motor cortex including diaschisis region were coronally sliced in 300 mm-thickness using a
vibrating microtome (VT1000S, Leica). The motor cortical region of each slice was mechanically dissociated with a round-tip of
vibrating polished glass pipette, connected to an alternating electronic relay switch (Omron G2R-2-S) under the control of function
generator (EZ digital) at 100-Hz rectangular wave function. The aCSF solution containing dissociated cells were collected and centri-
fuged at 1,000 rpm for 5 min. The collected cells were plated on 0.1 mg/mL PDL-coated cover glass, and placed in an incubator for
about 2 h before use. The cell preparation including the time of stabilization was validated in previous studies (Lalo et al., 2011; Lalo
et al., 2014; Lalo et al., 2006).
HEK293T cells, originated from Korean Cell Line Bank andmycoplasma free, expressing GABACR and EGFP were added onto the
cover glass with acutely dissociated cells. According to a previous report, astrocytes can be identifiedmorphologically. To determine
whether GFP-expressing HEK293T cells express GABACR, 100 mM GABA was bath-applied to induce GABACR-mediated full cur-
rent. GABACR-mediated currents were recorded from HEK293T cells expressing GABACR under voltage clamp (Vh =70 mV) using
Multiclamp 700B amplifier (Molecular Devices), acquired with pClamp 9.2. Recording pipettes were filled with (in mM): 140 CsCl, 0.5
CaCl2, 10 HEPES, 4 Mg-ATP, 0.3 Na3-GTP and 10 EGTA (pH adjusted to 7.3 with CsOH) and osmolality adjusted to 290–310 mOsm
kg-1 with sucrose.
Flow Cytometry with acutely dissociated astrocytes
Flow cytometry was performed to confirm that acutely dissociated cells contain a significant portion of astrocytes, and the cell are live
and functional. All flow cytometry experiments were performed on a BD LSRFortessaTM SORP with 5 lasers and 18 detectors (BD),
controlled using FACSDivaTM software version 6, andwas analyzedwith using FlowJo V10 (BD). Debris and cell clumpswere discrim-
inated using forward scattering (FSC) and side scattering (SSC) gating.
Astrocyte phenotyping
The acutely dissociated cells were collected by and centrifuged at 1,000 rpm for 5 min. The cells were fixed in 4% PFA for 10 min at
4C, then washed with stain buffer with BSA (554657, BD) for 2 times by repeating centrifugation at 2,500 rpm and re-suspension.
Then, the fixed cells were incubated in the blocking buffer with 0.3% of Triton X-100 for 1 hour, and then labeled with a mixture of
primary antibodies in a blocking solution at 4C on a shaker overnight. The primary antibodies used for FACS analysis were chicken
anti-GFAP (1:500; Millipore ab5541) and mouse anti-NeuN (1:1000; Millipore MAB377). After washing in stain buffer 3 times by
repeating re-suspension and centrifugation at 3,000 rpm, the cells were incubated with corresponding fluorescent secondary anti-
bodies for 1 h and then washed with blocking buffer 3 times. Finally one drop of 7-AAD (1581611, Bio-Rad) was added to the cell
suspension and analyzed in order to discriminate dead cells. Flow cytometry analysis were preformed using of controls for deter-
mining appropriate gates, voltages and compensations required in flow cytometry.
Calcium flux measurement
To confirm that the acutely dissociated astrocytes are live and functional, Ca2+ flux analysis was performed using flow cytometry with
Oregon Green 488 BAPTA-1 AM (O6807, Thermofisher Scientific). For Ca2+ flux analysis, the acutely dissociated cells were incu-
bated with Oregon Green 5 mM solution in the external solution (150 NaCl, 10 HEPES, 3 KCl, 2 CaCl2, 2 MgCl2, 5.5 glucose, in
mM, pH adjusted to pH 7.3.) for 30 min at 37C. After incubation, cells were washed and then re-suspended in the external solution.
The fluorescence in each sample was analyzed using 530/30 filter. Baseline calcium levels were recorded for 30 s on the cytometer.
And the sample was removed and add TFLLR (50 mM) and immediately replaced for recording. After loading the compounds
continued recording for 300 s. Ca2+ flux experiments were performed on live, non-fixed cells.
Whole-cell patch-clamp
Prior to recording, 300 mm-thick motor cortex-containing slices from freshly prepared brains were incubated at room temperature for
at least 1 h in aCSF solution (inmM): 126NaCl, 24NaHCO3, 1NaH2PO4, 0.5 ascorbic acid, 2.5 KCl, 2.5 CaCl2, 2MgCl2, and 10D-(+)-
glucose, pH 7.4. For recording, slices were transferred to a recording chamber that was continuously perfused with aCSF solution
(flow rate = 2 mL/min). The slice chamber was mounted on the stage of an upright Olympus microscope and visualized with a 60 3
water immersion objective (NA = 0.90) with infrared differential interference contrast optics and a CCD camera and by using Imaging
Workbench software (Indec BioSystems). Whole-cell recordings were performed from pyramidal neurons located in the layer 2/3 of
motor cortex. The holding potential was 60 mV. Pipette resistance was typically 6–8 MU and the pipette was filled with an internal
solution (inmM): 135 CsCl, 4 NaCl, 0.5 CaCl2, 10 HEPES, 5 EGTA, 2Mg-ATP, 0.5 Na2-GTP, 10QX-314, pH adjusted to 7.2 with CsOH
(278–285mOsmol). Beforemeasuring tonic current, baseline current was stabilized with D-AP5 (50 mM) and CNQX (20 mM). Electrical
signals were digitized and sampled at 50-ms intervals with Digidata 1440A and Multiclamp 700B amplifier (Molecular Devices) using
pCLAMP 10.2 software. Data were filtered at 2 kHz. The amplitude of tonic GABA current was measured by the baseline shift
after L655,708 (1 mM), NO-711 (10 mM), SNAP-5114 (40 mM), and/or bicuculline (50 mM) administration using the Clampfit program.




Frequency and amplitude of spontaneous inhibitory post-synaptic currents (sIPSCs) before bicuculline administration was detected
and measured by Minianalysis (Synaptosoft). For the analysis of sIPSC frequency and amplitude, two cells from stroke+KDS group,
whose Ra was over 40 MU, were excluded.
Electron microcopy and toluidine blue staining
Rat brains with diaschisis lesion in the microPET images were perfused with 1% paraformaldehyde/0.1% glutaraldehyde in cold
phosphate buffer (PB) delivered by a perfusion pump (36 mL/min) for 5 min, followed by 2% paraformaldehyde/2% glutaraldehyde
in cold PB at the same flow rate for 5 min. Brains were removed and coronally cut into 2-mm-thick slices. After the lesion was eval-
uated macroscopically in the brain slices, tissues were trimmed to approximately 23 23 1 mm, placed in 4% glutaraldehyde in PB
for 24 h at 4C, postfixed in 2% osmium tetroxide for 2 h at room temperature, rinsed in 0.1 mol/L cacodylate buffer, dehydrated in
graded concentrations of ethanol followed by propylene oxide, incubated in amixture of epon/propylene oxide (50/50, then 80/20 for
4 h), and embedded in epon at 60C in an oven for 2 days. Semi-thin sections (1-mm-thick) were stained with 1% toluidine blue and
screened by light microscopy to select thin section areas from multiple blocks at each lesion time-point for electron microscopy.
Selected thin sections (800-A thick) were cut with a diamond knife on an ultramicrotome (LKB-Produkter, Bromma), mounted on cop-
per grids, contrasted with uranyl acetate and lead citrate, and viewed on a JEOL 120S electron microscope.
For electron microcopy analysis, we used 2 sham animals and 4 stroke animals. For pathological examination and quantification of
synapse numbers in the diaschisis, we only used tissues of motor cortex. Tissues of sensory cortex were excluded because optical
fiber was introduced through sensory cortex. For quantification of synapse numbers, we used 24 and 29motor cortex sections from 2
sham and 4 stroke animals, respectively. The analyses were performed in a blinded manner by two independent neuropathologists.
Drug administration
KDS2010, a MAO-B inhibitor, was synthesized as previously descried (Park et al., 2019). Rats were habituated with 0.9% saline for
2 weeks prior to surgery. The compound was dissolved in distilled water and administered through oral route (10 mg/kg daily) for
3 weeks from 3 days following stroke operation in Stroke+KDS2010 and Stroke+rehab+KDS2010 group. To test the effect of
KDS2010 in Adeno-GFAP-GFP-injected rats, we administered KDS2010 from 3 days prior to virus injection to 1 week following virus
injection through dissolving the compound in drinking water. The amount of KDS2010 was calculated as 10 mg/kg daily. To test the
effect of L655,708 in stroke rats and Adeno-GFAP-GFP-injected rats, we intraperitoneally administered L655,708 (5 mg/kg) for once
30 minutes prior to FDG administration on the day of PET imaging.
Measurements of MAO-B enzyme activity
The enzymatic activity of MAO-B was measured as previously described (Jo et al., 2014). Rats were anesthetized and then the brain
was quickly excised from the skull and submerged in ice-cold cutting solution, which is the same as the cutting solution for tonic
GABA recordings. After cooling, cortical regions including somatosensory and motor cortex were isolated. The fresh tissues from
each rat were homogenized, and large debris was removed by weak centrifugation. Next, the supernatant was collected and centri-
fuged at 13,000 rpm for 20 min to obtain a mitochondria-rich fraction. The pellet was re-suspended in phosphate buffer, and 20 mg
were used in each well to determine the activity of theMao. Enzymatic activity of MAO-Bwasmeasured using an Amplex RedMono-
amine oxidase Assay Kit (Molecular Probes) according to the manufacturer’s instructions. After 30 min of enzyme reaction at 37C,
hydrogen peroxide, which is produced byMAO activity, is measured by a color change of Amplex red reagent. The color change was
quantified by measuring absorbance at 570 nm with Infinite M200 PRO microplate reader (TECAN).
Behavioral testing
Two types of behavioral tests were used in this study: the forelimb-use asymmetry test (cylinder test) was used to assess unskilled
motor behavior and the single-pellet reaching task (SPRT) was used to assess skilled motor behavior. To perform the cylinder test
(Hsu and Jones, 2005; Hua et al., 2002), animals were placed in a transparent Plexiglas cylinder (20 cm in diameter and 30 cm in
height) for two minutes to assess the frequency of usage of ipsilesional and contralesional forelimb to support an upright body
posture against the wall of the cylinder. We counted the number of ipsilateral and contralateral forepaw usages for each session.
The test score was calculated as the percentage of the number of ipsilateral usage to the total number of ipsilateral and contralateral
usages. For SPRT evaluation (Gharbawie et al., 2005), we used a clear Plexiglas (45 cm 3 13 cm 3 40 cm) box with a 1 cm wide
vertical slit and food shelf in the midline of the frontal wall. During the entire experimental period, animals were food-restricted to
90% of their body weight for motivating food retrieval. The preferred handedness of each rat was determined during the pre-training
by evaluating how successful the preferred paw was in retrieving sucrose pellets (Bio-Serve) that had been placed obliquely on the
shelf. A successful reachwas considered if the rat extended a forelimb to grasp the pellet, and brought it into themouth without drop-
ping it. The animals were administered 20 pellets per session for evaluation of motor performance. The reaching performance was
calculated as follows:
Number of successful reaches3100
20




Animals were trained daily for two weeks before photothrombotic stroke lesioning. Animals in the rehabilitation group (Stroke+rehab,
Stroke+rehab+KDS2010) and the sham group underwent daily postoperative training for 20 min for three weeks. Animals in the non-
rehabilitation groups (Stroke and Stroke+KDS2010) performed the reaching task twice per week for three weeks postoperatively and
on the day of sacrifice (i.e, a total of 6 post-operative training sessions). The analyses were performed by a blinded researcher.
Preparation and injection of putrescine and viruses
TheMAO-B shRNA sequence (antisense) is AATCGTAAGATACGATTCTGG. For lentivirus-based shRNA expression, a lentiviral vec-
tor containing the MAOB-shRNA gene was constructed into the HpaI–XhoI restriction enzyme sites of the pSicoR lentiviral vector, as
previously described (Yoon et al., 2014). To selectively knockdown astrocytic MAO-B, we injected AAV-GFAP-Cre-mCherry and
lentivirus containing pSico-MAOB-shRNA-GFP (or pSico-scrambled-shRNA-GFP for control) into the forelimb area of the motor cor-
tex (AP = 2.0 mm, ML = +/ 2.5 mm, DV =1.5 mm from bregma), using techniques as previously described (Song et al., 2017). A
mixture of 1 mL of AAV and 1 mL of lentivirus virus was slowly injected at the target site (layer 5 of forelimb area) with a rate of 0.1ml/min
using 30G Hamilton syringe connected to an UltraMicroPump (WPI). After injection, the needle was left in place for an additional
10 min before being slowly retracted. Postoperative pain was controlled with ketoprofen (2 mg/kg, i.m.).
To induce neuroinflammation including reactive astrocytosis with aberrant astrocytic GABA production, we developed Adeno-
GFAP-GFP plasmid. As a GFAP promoter, we used gfaABC1D promoter which is reported to be highly specific to astrocytes (Lee
et al., 2008). We prepared pAd-GFAP-GFP using Gateway gene cloning strategy. In detail, we first excised gfaABC1D-EGFP
from pTYF-1xGfaABC1D-EGFP (Addgene, #19974). Next, for constructing a packaging backbone plasmid containing attB recom-
bination sites for the shuttle vector plasmid to be recombined into, we obtained attB1-GFAP-GFP-attB2 sequence through PCRwith
primer containing attB1 and attB2. Then, Gateway BP reaction was performed using this attB1-GFAP-GFP-attB2 sequence and
pDonor vector (Invitrogen, 12536017) to obtain pDonor-GFAP-GFP plasmid. Finally, Gateway LR reaction was performed using
this plasmid with pAd/PL-DEST vector (Invitrogen, V49420) to obtain pAd-GFAP-GFP plasmid.
To confirm whether astrocytic GABA induces cortical diaschisis, we injected 2 mL of Adeno-GFAP-GFP (N = 8) or 2 mM putrescine
(N = 8) into the forelimb area of themotor cortex (AP =2.0mm,ML = +/ 2.5mm, DV =1.5mm from bregma) using techniques in a
same way. Animals in the control group (N = 8) underwent the same procedure except that they received an injection of 0.9% saline
(2 mL) instead of Adenovirus and putrescine. To investigate whether KDS2010 and L655,708 reverses Adeno-GFAP-GFP-
induced decrease in FDG uptake, we injected 1.5 uL of Adeno-GFAP-GFP into M1 motor cortex (AP = 0.2 mm, ML = +/
2.0 mm, DV =1.5 mm from bregma) and S1 somatosensory cortex (AP =0.2mm,ML = +/ 4.0mm, DV =2.5 mm from bregma).
To induce a severe lesion in the cortex, we injected 2 uL of 100 mM putrescine into five consecutive points into the motor cortex
(1: AP = 0.5 mm, ML = +1.5 mm from bregma, DV = 1.3 mm from dura; 2: AP = +1.0 mm, ML = +3.0 mm from bregma, DV =
1.3 mm from dura; 3: AP = +2.0 mm, ML = +2.5 mm from bregma, DV = 1.3 mm from dura; 4: AP = +3.0 mm, ML = +1.5 mm
from bregma, DV = 1.3 mm from dura; 5: AP = +3.0 mm, ML = +4.0 mm from bregma, DV = 1.3 mm from dura). Animals in the
control group (N = 8) underwent the same procedure except that they received an injection of 0.9% saline (2 mL) instead of putrescine.
Quantitative real-time RT-PCR
Quantitative real-time RT-PCRwas carried out using SYBRGreen PCRMaster Mix. In brief, reactions were performed in triplicates in
a total volume of 10 mL containing 10 pM primer, 4 mL cDNA, and 5 mL power SYBR Green PCR Master Mix (Applied Biosystems).
The mRNA level of each gene was normalized to that ofGapdhmRNA and fold-induction was calculated using the 2–DDCTmethod.
The following sequences of primerswere used.Gfap forward: 50-GAAGAAAACCGCATCACCAT-30;Gfap reverse: 50-TCCTTAATG
ACC TCGCCA TC-30;Maob forward: 50-CGAGAC AGC TTC ACA TTGGA-30;Maob reverse: 50-GCC AAA TTT CAT CCT CTGGA-30;
Inos forward: 50-CCT GTG TTC CAC CAG GAG AT-30; Inos reverse: 50-CGC TTT CAC CAA GAC TGT GA-30; Lcn2 forward: 50-TCA
CCC TGT ACG GAA GAA CC-30; Lcn2 reverse: 50-TCG GTG GGA ACA GAG AAA AC-30; Vimentin forward: 50-AGA TCG ATG TGG
ACG TTT CC-30; Vimentin reverse: 50-TCC GGT ATT CGT TTG ACT CC-30; C3 forward: 50-GAA GCC CTA GTG GGG AAG TC-30; C3
reverse: 50-AAC ACC ATG AGG TCG AAA GG-30; Gapdh forward: 50-ACC CAG AAG ACT GTG GAT GG-30; Gapdh reverse: 50-CAC
ATT GGG GGT AGG AAC AC-30.
QUANTIFICATION AND STATISTICAL ANALYSIS
Image quantification
Confocal microscopic images were analyzed using the ImageJ program (NIH).. For analyzing GABA intensity in GFAP+ astrocytes or
PV+ interneurons, every image was first converted to 16-bit image, then converted into binary. Every GFAP+ astrocyte or PV+ inter-
neuron was picked as a region of interest (ROI). And the binary GFAP+ image and GABA+ image were multiplied to remaining GABA+
signal only in the GFAP+ pixels. In this multiplied image, the mean intensity value of GABA in every ROI wasmeasured. Quantification
of LCN2 intensity in GFAP+ astrocytes was performed in the same way as quantification of GABA intensity. For quantifying GFAP+
area of a GFAP+ astrocyte, we measured mean intensity from 16-bit binary GFAP+ image. To quantify the reactivity of astrocytes, we
performed Sholl analysis with a plugin provided by ImageJ program. To perform Sholl analysis, we used the ROIs described above
from 16-bit binary GFAP+ images. Radius step size was 10 mm and the number of primary branches were automatically inferred from
starting radius.





Data were analyzed with Prism 7 (GraphPad). Time-dependent changes in cortical diaschisis volume, NMA, and behaviors were
analyzed using two-way ANOVA (p < 0.05, Bonferroni correction for multiple comparisons). Differences between two different groups
were analyzed with the two-tailed Student’s unpaired t test. For assessment of change of a group by a certain intervention, the sig-
nificance of data was assessed by the two-tailed Student’s paired t test. For comparison of multiple groups, one-way analysis of
variance (ANOVA) with Tukey’s or Dunnett’s multiple comparison test was assessed. All data are represented as mean ± standard
error of the mean (SEM). The significance level is represented as asterisks (*p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant).
For the longitudinal PET study, a group-level linear mixed-effect model was performed with the 3dLME program of AFNI to assess
differences between baseline (PL 1) and PL 7, 14, and 21 images for each group of animals. Statistical maps were corrected and
thresholded at the significance level (p < 0.001, false discovery rate q < 0.05). In addition, we conducted a voxel-wise paired t test with
3dttest in AFNI to compare pre-injection versus post-injection scan (AAV, putrescine, and saline injection groups). Monte Carlo simu-
lation was used with 3dClustSim program in AFNI, and statistical maps were thresholded at p < 0.01 and the minimum cluster size of
39 voxels with p < 0.05. The resulting statistical maps overlaid on the template to show areas of significant brain activity changes. An
ROI was manually defined in ipsilesional motor cortex to identify the longitudinal changes of NMA. In addition, using Pearson’s cor-
relation (p < 0.05), we examined correlations between NMA changes in ROI and intensity of astrocytic GABA, and correlations be-
tween NMA changes or volume of cortical diaschisis and SPRT scores.
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